Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

GLP-1 Drugs Linked to Lower Fracture Risk in People With Type 2 Diabetes

Glucagon-like peptide-1 (GLP-1) receptor agonists may be associated with a lower risk of fragility fracture in patients with type 2 diabetes, a study published in JAMA Network Open found.

We haven't written up this one. JAMA has the full story — the link below goes straight to it.

Read the original at jamanetwork.com →

More in Health & Medicine

DIPHTHERIA CRISIS: THE IMMUNISATION GAP

PAT ONUKWULI argues for surveillance and a catch-up vaccination in schools and communities An earlier article, “Nigeria’s Immunisation Gap,” warned that vaccine availability must not be mistaken for…

More from Tuesday 15 September →